TYMS and neoplasm: To evaluate the relation between the level of TS expression in NSCLC tumours and the clinical response to pemetrexed, we performed semiquantitative immunohistochemical analysis on tumour biopsy specimens from 24 patients with advanced NSCLC treated with pemetrexed combined with platinum agents (Figure 6A).